The online pharmacy is set to announce a series D round that will be led by $250m from SoftBank Vision Fund at a valuation in excess of $1bn.
Internet and telecommunications group SoftBank’s Vision Fund has invested $250m to lead a series D round of undisclosed size for US-based medicine delivery service Alto Pharmacy, Reuters reported yesterday.
The round valued Alto at more than $1bn and included investment firm Greenoaks Capital and venture capital firm Jackson Square Ventures, according to two people familiar with the development.
Formerly known as ScriptDash, Alto runs an online pharmacy that manages prescriptions, delivers medication and offers discounts as well as support on…
